Clinical Trial Update: Study of Antidepressants in Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating antidepressants in Parkinson's disease has completed and the results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Snippet

Sponsor: University of Rochester | Conditions: Parkinson Disease, Depression | Phase 3 | Status: COMPLETED | Results posted: 2013-01-04